Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Liabilities ₹1,026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹1,026 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹1,026 Cr
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹1,026 Cr
16.58
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹297.4 Cr 3.8% -8.3% -14.1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,796.5 Cr -1.4% -9.1% -27% Stock Analytics
KAVERI SEED COMPANY ₹5,106.4 Cr 4.4% -5.8% 10.5% Stock Analytics
VENKYS (INDIA) ₹1,895.5 Cr 0.6% -8.5% -21.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,102.7 Cr -6.5% -14.2% -26.4% Stock Analytics
INDO US BIOTECH ₹272.8 Cr 16.7% -3.5% -40.7% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

3.8%

-8.3%

-14.1%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses